SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-054337
Filing Date
2023-05-01
Accepted
2023-05-01 16:05:36
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2313834d1_10ka.htm   iXBRL 10-K/A 238103
2 EXHIBIT 31.1 tm2313834d1_ex31-1.htm EX-31.1 4212
3 EXHIBIT 31.1 tm2313834d1_ex31-2.htm EX-31.2 4148
  Complete submission text file 0001104659-23-054337.txt   498266

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA btai-20221231.xsd EX-101.SCH 3066
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE btai-20221231_lab.xml EX-101.LAB 36509
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btai-20221231_pre.xml EX-101.PRE 24020
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2313834d1_10ka_htm.xml XML 5637
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38410 | Film No.: 23873547
SIC: 2834 Pharmaceutical Preparations